{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:05:30Z","timestamp":1791108330206,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2,15]]},"DOI":"10.1097\/tp.0b013e3181c6ff8d","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T01:16:58Z","timestamp":1265159818000},"page":"277-284","source":"Crossref","is-referenced-by-count":172,"title":["Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection"],"prefix":"10.1097","volume":"89","author":[{"given":"R Carlin","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Everly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele H.","family":"Rike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois J.","family":"Arend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham","family":"Mogilishetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Govil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabir","family":"Roy-Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita R.","family":"Alloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Steve","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2009.02577.x","article-title":"Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.","volume":"9","author":"Everly","year":"2009","journal-title":"Am J Transplant"},{"key":"R2-4-20210211","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"R3-4-20210211","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-6143.2006.01632.x","article-title":"The effect of desensitization protocols on human splenic B-cell populations in vivo.","volume":"7","author":"Ramos","year":"2007","journal-title":"Am J Transplant"},{"key":"R4-4-20210211","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"R5-4-20210211","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.iy.01.040183.000341","article-title":"Cellular mechanisms of immunologic tolerance.","volume":"1","author":"Nossal","year":"1983","journal-title":"Annu Rev Immunol"},{"key":"R6-4-20210211","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0952-7915(98)80169-6","article-title":"Inhibitory signaling by B cell Fc gamma RIIb.","volume":"10","author":"Coggeshall","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"R7-4-20210211","doi-asserted-by":"crossref","first-page":"13489","DOI":"10.1073\/pnas.1935944100","article-title":"The inhibitory potential of Fc receptor homolog 4 on memory B cells.","volume":"100","author":"Ehrhardt","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-4-20210211","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat Immunol"},{"key":"R9-4-20210211","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.23.021704.115723","article-title":"Maintenance of serum antibody levels.","volume":"23","author":"Manz","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R10-4-20210211","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: A suitable antineoplastic target.","volume":"4","author":"Adams","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R11-4-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-4652(2001)9999:9999<1::AID-JCP1049>3.0.CO;2-O","article-title":"Ubiquitin-mediated proteolysis of vertebrate G1- and S-phase regulators.","volume":"187","author":"Yew","year":"2001","journal-title":"J Cell Physiol"},{"key":"R12-4-20210211","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0959-437X(99)00049-0","article-title":"Proteolysis and the cell cycle: With this RING I do thee destroy.","volume":"10","author":"Tyers","year":"2000","journal-title":"Curr Opin Genet Dev"},{"key":"R13-4-20210211","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1600-6143.2009.02612.x","article-title":"Mechanisms of alloantibody production in sensitized renal allograft recipients.","volume":"9","author":"Stegall","year":"2009","journal-title":"Am J Transplant"},{"key":"R14-4-20210211","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/TP.0b013e3181837626","article-title":"Transplant glomerulopathy: Risk and prognosis related to anti-human leukocyte antigen class II antibody levels.","volume":"86","author":"Issa","year":"2008","journal-title":"Transplantation"},{"key":"R15-4-20210211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000170813","article-title":"Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs rituximab-treated non-splenectomy preconditioning regimens.","volume":"162","author":"Tanabe","year":"2009","journal-title":"Contrib Nephrol"},{"key":"R16-4-20210211","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-2277.2008.00821.x","article-title":"Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients.","volume":"22","author":"Toki","year":"2009","journal-title":"Transpl Int"},{"key":"R17-4-20210211","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.","volume":"67","author":"Meister","year":"2007","journal-title":"Cancer Res"},{"key":"R18-4-20210211","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humimm.2005.01.032","article-title":"Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.","volume":"66","author":"Zachary","year":"2005","journal-title":"Hum Immunol"},{"key":"R19-4-20210211","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/TP.0b013e3181a4b91b","article-title":"Abrogation of anti-HLA antibodies via proteasome inhibition.","volume":"87","author":"Trivedi","year":"2009","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181c6ff8d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:52Z","timestamp":1786040332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201002150-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,15]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181c6ff8d","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2,15]]}}}